Results Healthcare is delighted to announce that it has advised Prescient Healthcare Group, a leading product strategy consultancy to the global biopharmaceutical industry, on securing growth equity investment from Baird Capital.
Founded in 2007, Prescient is headquartered in London with offices in the US, India and China. The business provides decision support services to help its clients make better clinical and commercial decisions resulting in enhanced outcomes for patients, customers and shareholders. Prescient partners with many of the leading multinational pharmaceutical companies, as well as a growing number of emerging biotech organisations.
The management team of Prescient engaged Results Healthcare to help them find a partner to support their growth and investment in innovative new products. Results acted as sole financial advisor on the transaction.
Results Healthcare, leading M&A adviser focused on public and private healthcare and life science companies.